Home / Inspections / 1220112

FDA Inspection 1220112 — Biomat USA, Inc

Biomat USA, Inc — FEI 2377779

The FDA completed an inspection of Biomat USA, Inc on September 29, 2023 in Bellflower, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 29, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Bellflower, CA (United States)

Facility

Other inspections at this facility

  • 1122354 (NAI Fri Mar 06 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1023195 (NAI Thu Jul 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 940447 (NAI Fri Aug 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 806108 (NAI Thu Nov 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 681964 (NAI Thu Sep 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources